ANDREW CIVITELLO to Retrospective Studies
This is a "connection" page, showing publications ANDREW CIVITELLO has written about Retrospective Studies.
Connection Strength
0.509
-
Impact of time off anticoagulation in patients with continuous-flow left ventricular assist devices. J Artif Organs. 2023 Dec; 26(4):275-286.
Score: 0.059
-
Medium to long-term ventricular assist device support in adults with congenital heart disease. J Heart Lung Transplant. 2025 Feb; 44(2):278-281.
Score: 0.017
-
Mortality in Recipients of Durable Left Ventricular Assist Devices Undergoing Ventricular Tachycardia Ablation. JACC Clin Electrophysiol. 2024 Sep; 10(9):2049-2058.
Score: 0.017
-
Kidney Function Trajectories and Right Heart Failure Following LVAD Implantation. J Am Heart Assoc. 2024 Mar 05; 13(5):e031305.
Score: 0.016
-
Sex Disparities in Left Ventricular Assist Device Implantation: Delayed Presentation and Worse Right Heart Failure. ASAIO J. 2024 06 01; 70(6):469-476.
Score: 0.016
-
Clinical Predictors and Outcomes After Left Ventricular Assist Device Implantation and Tracheostomy. Tex Heart Inst J. 2023 08 22; 50(4).
Score: 0.016
-
Impact of the 2018 UNOS Heart?Transplant Policy Changes on?Patient?Outcomes. JACC Heart Fail. 2023 05; 11(5):491-503.
Score: 0.015
-
Continuous-Flow Ventricular Assist Device Support in Adult Congenital Heart Disease: A 15-Year, Multicenter Experience of Temporary and Durable Support. ASAIO J. 2023 05 01; 69(5):429-437.
Score: 0.015
-
Distinctive kidney function trajectories following left ventricular assist device implantation. J Heart Lung Transplant. 2022 12; 41(12):1798-1807.
Score: 0.015
-
The influence of preoperative dialysis on survival after continuous-flow left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2022 02 21; 34(3):470-477.
Score: 0.014
-
Continuous-Flow Left Ventricular Assist Device Support in Patients with Ischemic Versus Nonischemic Cardiomyopathy. Tex Heart Inst J. 2021 Sep 01; 48(4).
Score: 0.014
-
Extracorporeal membrane oxygenation as a bridge to durable left ventricular assist device implantation in INTERMACS-1 patients. J Artif Organs. 2022 Mar; 25(1):16-23.
Score: 0.013
-
Predictors of renal replacement therapy in patients with continuous flow left ventricular assist devices. J Artif Organs. 2021 Jun; 24(2):207-216.
Score: 0.013
-
Survival on the Heart Transplant Waiting List. JAMA Cardiol. 2020 11 01; 5(11):1227-1235.
Score: 0.013
-
Accuracy of Postoperative Risk Scores for Survival Prediction in Interagency Registry for Mechanically Assisted Circulatory Support Profile 1 Continuous-Flow Left Ventricular Assist Device Recipients. ASAIO J. 2020 05; 66(5):539-546.
Score: 0.013
-
Gastrointestinal Bleeding After HeartMate II or HVAD Implantation: Incidence, Location, Etiology, and Effect on Survival. ASAIO J. 2020 03; 66(3):283-290.
Score: 0.012
-
Outcomes of Repeat Left Ventricular Assist Device Exchange. ASAIO J. 2020 01; 66(1):64-68.
Score: 0.012
-
Effect of cardiac arrest with aortic cross-clamping during left ventricular assist device implantation. Interact Cardiovasc Thorac Surg. 2020 01 01; 30(1):47-53.
Score: 0.012
-
Long-Term Continuous-Flow Left Ventricular Assist Device Support After Left Ventricular Outflow Tract Closure. ASAIO J. 2019 08; 65(6):558-564.
Score: 0.012
-
Concomitant valve procedures in patients undergoing continuous-flow left ventricular assist device implantation: A single-center experience. J Thorac Cardiovasc Surg. 2019 10; 158(4):1083-1089.e1.
Score: 0.012
-
Severe LVAD-related infections requiring surgical treatment: Incidence, predictors, effect on survival, and impact of device selection. J Card Surg. 2019 Feb; 34(2):82-91.
Score: 0.012
-
A left ventricular end-diastolic dimension less than 6.0?cm is associated with mortality after implantation of an axial-flow pump. J Thorac Cardiovasc Surg. 2019 06; 157(6):2302-2310.
Score: 0.011
-
Fatal Neurologic Dysfunction During Continuous-Flow Left Ventricular Assist Device Support. Ann Thorac Surg. 2019 04; 107(4):1132-1138.
Score: 0.011
-
Effect of Preoperative Atrial Fibrillation on Patients with Chronic Heart Failure Who Undergo Long-Term Continuous-Flow LVAD Implantation. ASAIO J. 2018 Sep-Oct; 64(5):594-600.
Score: 0.011
-
Predictive value of preoperative serum albumin levels on outcomes in patients undergoing LVAD implantation. J Card Surg. 2018 Aug; 33(8):469-478.
Score: 0.011
-
HeartMate II implantation technique that spares the sternum and ascending aorta. J Artif Organs. 2018 Dec; 21(4):458-461.
Score: 0.011
-
Acute kidney injury after implantation of a left ventricular assist device: a comparison of axial-flow (HeartMate II) and centrifugal-flow (HeartWare HVAD) devices. J Artif Organs. 2018 Sep; 21(3):285-292.
Score: 0.011
-
Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2018 08; 106(2):513-519.
Score: 0.011
-
Bridging to a Long-Term Ventricular Assist Device With Short-Term Mechanical Circulatory Support. Artif Organs. 2018 Jun; 42(6):589-596.
Score: 0.011
-
Effect of obesity on outcomes in patients undergoing implantation of continuous-flow left ventricular assist devices. J Artif Organs. 2018 Jun; 21(2):180-187.
Score: 0.011
-
Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle. Ann Thorac Surg. 2018 03; 105(3):799-806.
Score: 0.011
-
Incidence, Predictors, and Significance of?Ventricular Arrhythmias in Patients With?Continuous-Flow Left Ventricular Assist Devices: A 15-Year Institutional Experience. JACC Clin Electrophysiol. 2018 02; 4(2):257-264.
Score: 0.011
-
Frequency and Consequences of Right-Sided Heart Failure After Continuous-Flow Left Ventricular Assist Device Implantation. Am J Cardiol. 2018 02 01; 121(3):336-342.
Score: 0.011
-
Outcomes in patients with advanced heart failure and small body size undergoing continuous-flow left ventricular assist device implantation. J Artif Organs. 2018 Mar; 21(1):31-38.
Score: 0.010
-
Preoperative Prealbumin Level as a Predictor of Outcomes in Patients Who Underwent Left Ventricular Assist Device Implantation. Am J Cardiol. 2017 Dec 01; 120(11):1998-2002.
Score: 0.010
-
Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure. J Thorac Cardiovasc Surg. 2015 Jan; 149(1):267-75, 278.e1.
Score: 0.008
-
Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation. J Heart Lung Transplant. 2008 Jan; 27(1):106-11.
Score: 0.005
-
Use of the TandemHeart percutaneous ventricular assist device to support patients undergoing high-risk percutaneous coronary intervention. J Invasive Cardiol. 2006 Mar; 18(3):93-6.
Score: 0.005